Mankind Pharma Acquires Bharat Serums and Vaccines For Rs 13,600 Crore
Mankind Pharma has entered into a definitive agreement to acquire a 100 per cent stake in Bharat Serums and Vaccines (BSV) from Advent International. It is one of the world’s largest and most experienced private equity investors, for an enterprise value of Rs 13,630 crore, subject to closing related adjustments.
Mankind Pharma is one of the largest pharmaceutical companies in India, which focuses on the domestic market with its pan India presence. Mankind operates at the intersection of the Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices.
Shares of Mankind Pharma will be in focus during the trading session on July 26, after the pharmaceuticals company announced to acquire Bharat Serums and Vaccines (BSV) from Advent International to expand its high entry barrier portfolio and gain leadership in women’s health.
This strategic move marks a leap for Mankind Pharma, positioning it as a market leader in the Indian women’s health and fertility drug market alongside access to other high entry barrier products in critical care with established complex R&D tech platforms, the company added.
Shares of Mankind Pharma settled at Rs 2143.90 on July 26, rising more than 1.81 per cent for the day. The total market capitalization of the company stood close to Rs 86,000 crore as the previous close. Shares of Mankind Pharma were listed on the bourses in May 2023. The company raised a total of Rs 4,326.36 crore via its initial public offering (IPO) as it sold its shares for Rs 1,080 apeice. The stock has nearly doubled value from its IPO price, rising more than 98 per cent.
BSV has developed recombinant and niche biologic products in-house, demonstrating its strong R&D capabilities and boasts of a robust branded product portfolio across women’s health, fertility and critical care, with a few of its marque brands enjoying a strong leadership position in their respective therapy areas with over five decades of leadership in biopharmaceuticals.
BSV’s acquisition represents a pivotal milestone in Mankind’s journey, establishing us as market leader in Indian women’s health & fertility segment, said Rajeev Juneja, Vice-chairman and Managing Director, Mankind Pharma.
Greenland’s parliament has passed a tripartite security agreement between Denmark and the United States to…
Collins Dictionary has chosen ‘mogging’ as its word of the year for 2026. The slang…
The state government of Uttarakhand has declared November 28th as the annual ‘Disaster Management Day’…
India has been re-elected as President for the third time at the ninth session of…
Keisha Lance Bottoms has made history by becoming the first Black woman ever to be…
The QS World University Rankings: Asia 2027 were released on 3rd November 2026 by Quacquarelli…